Pioneering Electrospinning Technology with Unmatched Expertise
Driven by innovation, ElectrospinTEK empowers global researchers and industries with precision nanofiber solutions.
Company Overview
At ElectrospinTEK, we specialize in the development and manufacturing of advanced electrospinning machines—from benchtop R&D units to fully customized industrial-scale systems. As a proud subdivision of Matregenix Inc., we combine deep material science expertise with next-generation engineering to enable scalable nanofiber production across a range of industries.
Our mission
We serve academic institutions, research labs, and manufacturing partners worldwide who are looking to unlock the full potential of nanofiber-based technologies in fields like biomedical engineering, air filtration, pharmaceuticals, energy storage, and functional textiles.
Our team brings together over a decade of hands-on electrospinning experience, ensuring that every machine is built with precision, reliability, and flexibility in mind.
Whether you’re developing drug delivery scaffolds or scaling up nanofiber filtration media, ElectrospinTEK is your trusted partner in nanofiber production technology.
Why Choose ElectrospinTEK
With our roots in Matregenix, we offer unique know-how in working with polymers, composite materials, and functional additives for nanofiber applications. We support:
- Single-needle and multi-needle systems
- Coaxial and tri-axial electrospinning
- Turbo and needleless electrospinning
Solvent and aqueous-based formulations
Built by Experts, for Innovators
ElectrospinTEK machines are engineered by a team that understands both the scientific and industrial sides of electrospinning. From solution properties to process optimization, we provide tools designed by people who use them.
Research-Backed
Innovation
Our machines are developed in partnership with researchers and practitioners who push the boundaries of what nanofibers can do. We actively support innovation in tissue engineering, wound care, filtration, and more.
R&D Services and
Technology Transfer
Beyond machine manufacturing, we provide contract development, proof-of-concept prototyping, and technology transfer services. Whether you need help developing your nanofiber product or adapting a lab method to an industrial setting, we’re here to help.
Modular, Scalable
Solutions
Whether you’re starting with a lab-scale setup or scaling up to industrial throughput, our platforms are fully modular and customizable. Easily upgrade your system as your research or production needs evolve.
Global Support and Collaboration
We ship and support clients across North America, Europe, Asia, and the Middle East, offering installation, training, and consultation services. Our team is always available to assist with system integration, process troubleshooting, and material compatibility testing.
Leadership
Sherif Soliman
Ph.D., MBA - Chief Executive Officer
Highly passionate, and quality-driven, Dr. Sherif Soliman is a leading Material Scientist and founder of Matregenix. For over 20 years, Sherif has built on his extensive experience in biomaterials and nanofibers research and has planned, designed, and executed numerous nanofibrous polymeric structures for medical applications. His historical achievements in the creation of tissue scaffolds, as well as his expertise in medical device manufacturing, have earned him a reputation as a trusted partner to thought leaders and industry experts throughout the globe. One of his most rewarding achievements took place when a tissue-engineered scaffold he designed and developed became the first synthetic whole organ in medical history to be implanted into a patient.
As a native of the Sinai desert of Egypt, Sherif felt called to make difference beyond his home country and has always admired medical innovations and the strong correlation between science and engineering.
Sherif holds a Ph.D. in Material Science and Engineering from the University of Rome Tor Vergata, though much of his research was conducted as a visiting research fellow at Harvard Medical School. Following that, Sherif completed postdoctoral fellowships, the first one at MIT, and the second was an eminent T32 fellowship from NIH at Princeton University. Sherif also graduated from the Executive MBA program at Questrom School of Business and earned a BS in Biomedical Engineering. He holds several patents and has authored many peer-reviewed research papers in top tier journals. Recently, Sherif volunteered to author a new ASTM guideline for the characterization of fiber-based scaffolds for tissue engineering medical products.
Kevin Guo
Ph.D. - Chief Operating Officer
Dr. Guo is an exceptionally innovative Research and Development Scientist with a mastery in nanotechnologies and microfluidic fabrication. With over eight years of multidisciplinary research experience, Kevin has profound expertise in scientific research, laboratory management, analytical technology, scientific literature, and instrumentation, making him a suburb resource to cultivate ideal operational improvements that foster business growth.
Kevin brings a very thunderous, naturistic approach to the Matregenix culture. He has always been ardent about the environment and protecting the planet, and aims to create a sustainable future using novel technologies. Because Kevin has been so powerfully motivated by this rooted mission throughout his life, while earning his Ph.D. in Chemical Engineering from the University of Wyoming, he designed all his experiments and tracked his Department of Energy projects in order to mitigate climate change. As someone with a passion for the environment and being at the forefront of medical innovation, it is no secret that Kevin genuinely admires his roles, and is continuously improving himself both personally and professionally to deliver valuable, scientific advancements that result in
Omar Merhi, PhD
Chief innovation officer
Omar Merhi, PhD is a seasoned Medical Device Executive with deep expertise in planning and executing Go-To-Market strategies, and global clinical and regulatory programs for cardiovascular, orthopedic, hemodynamic, and other Class I, II & Class III devices. He has orchestrated multi-phase clinical trials, Investigator-Sponsored Studies, and Real-World Evidence (RWE) initiatives at leading companies like Orthofix, Smith & Nephew, J&J, Alcon (a Novartis company), Abbott, and Boston Scientific, consistently aligning with FDA and EU regulations.
Dr. Merhi has led cross-functional teams encompassing clinical operations, data analytics, medical writing, and vendor management, collaborating closely with key opinion leaders and regulatory bodies. His achievements include securing rapid market approvals, developing effective reimbursement strategies, and cutting study costs through strategic budgeting and recruitment efficiencies.
Possessing a strong scientific foundation in kinesiology, human factors, and movement science, he generates compelling clinical evidence to advance product success and patient outcomes. Fluent in English, French, and Arabic, Dr. Merhi embraces authentic leadership and fosters high-performance teams across diverse global settings. Omar is also a volleyball veteran, having played in Lebanon, Turkey, France, and the United States at both

Ed O’Sullivan
J.D., MBA- Director of Business Development
Ed O’Sullivan is a seasoned entrepreneur with a robust track record of building, buying, and selling businesses. With years of experience in the business development landscape, Ed has become a trusted advisor to numerous startups and small enterprises, offering strategic guidance and counsel to foster their growth and success.
For over 17 years, Ed has owned and operated Payer Tech, an innovative IT company specializing in claims transaction services for the healthcare insurance industry. Under his leadership, Payer Tech has become a trusted partner for healthcare providers and insurers, delivering efficient and reliable solutions that streamline claims processing and enhance operational efficiency.
Ed’s entrepreneurial journey is marked by his keen ability to identify market opportunities and drive business transformation. He has a deep understanding of the challenges and opportunities that startups face and leverages his extensive knowledge to help them navigate complex business environments. His expertise in business strategy, combined with his legal and financial acumen, has enabled him to successfully lead numerous ventures to sustainable growth and profitability.
In his role as Director of Business Development, Ed continues to apply his strategic vision and

Stephen Bumb
Chief Commercialization Officer
Stephen is a seasoned senior healthcare technologies marketing executive with extensive experience in driving the commercialization of innovative technologies for emerging companies. Over his illustrious career, Stephen has played a pivotal role in the senior leadership teams of five startups, guiding them through critical growth phases and market entry. His expertise also extends to transforming business strategies at Fortune 500 companies, including industry giants like Edwards Lifesciences and Canon Medical.
Throughout his career, Stephen has demonstrated a remarkable ability to engage with a diverse range of clinical disciplines, having worked closely with over 20 different specialties. His leadership has been instrumental in the successful commercialization of more than 25 major product platforms, underscoring his deep understanding of the healthcare market and his strategic acumen.
Currently, Stephen serves as the Principal of AR-TIC-U-LATE Medtech, a consultancy firm dedicated to providing comprehensive Go To Market strategy design and execution services for emerging medical technology companies. His passion for innovation and commitment
Advisory
Board
Michael Francis
Michael Francis
Matthew Becker
Matthew Becker
Fauad Hasan
Fauad Hasan
Omer Merhi
Omer Merhi
Kelly Kambs
Kelly Kambs
Mohamed Kamel
Mohamed Kamel
Samir Shreim
Samir Shreim
Marco C. Bottino
Marco C. Bottino
JP Powers
JP Powers
Testimonials
Case Studies
Precision-engineered nanofiber equipment empowering researchers and industries worldwide